102 related articles for article (PubMed ID: 8027558)
41. Three novel mutations in the interleukin-2 receptor gamma chain gene in four Japanese patients with X-linked severe combined immunodeficiency.
Minegishi Y; Ishii N; Maeda H; Takagi S; Tsuchida M; Okawa H; Sugamura K; Yata J
Hum Genet; 1995 Dec; 96(6):681-3. PubMed ID: 8522327
[TBL] [Abstract][Full Text] [Related]
42. Molecular mechanisms regulating the hyaluronan binding activity of the adhesion protein CD44.
Chiu RK; Droll A; Cooper DL; Dougherty ST; Dirks JF; Dougherty GJ
J Neurooncol; 1995 Dec; 26(3):231-9. PubMed ID: 8750189
[TBL] [Abstract][Full Text] [Related]
43. Function of the interleukin-2 (IL-2) receptor gamma-chain in biologic responses of X-linked severe combined immunodeficient B cells to IL-2, IL-4, IL-13, and IL-15.
Matthews DJ; Clark PA; Herbert J; Morgan G; Armitage RJ; Kinnon C; Minty A; Grabstein KH; Caput D; Ferrara P
Blood; 1995 Jan; 85(1):38-42. PubMed ID: 7803808
[TBL] [Abstract][Full Text] [Related]
44. Interleukin-2 receptor gamma-chain mutations in severe combined immunodeficiency with B-lymphocytes.
Tsuge I; Matsuoka H; Abe T; Kamachi Y; Torii S
Eur J Pediatr; 1996 Dec; 155(12):1018-24. PubMed ID: 8956936
[TBL] [Abstract][Full Text] [Related]
45. Sharing of a common gamma chain, gamma c, by the IL-2, IL-4, and IL-7 receptors: implications for X-linked severe combined immunodeficiency (XSCID).
Leonard WJ; Noguchi M; Russell SM
Adv Exp Med Biol; 1994; 365():225-32. PubMed ID: 7887307
[No Abstract] [Full Text] [Related]
46. Canine X-linked severe combined immunodeficiency.
Felsburg PJ; Hartnett BJ; Henthorn PS; Moore PF; Krakowka S; Ochs HD
Vet Immunol Immunopathol; 1999 Aug; 69(2-4):127-35. PubMed ID: 10507300
[TBL] [Abstract][Full Text] [Related]
47. Functional participation of the IL-2 receptor gamma chain in IL-7 receptor complexes.
Kondo M; Takeshita T; Higuchi M; Nakamura M; Sudo T; Nishikawa S; Sugamura K
Science; 1994 Mar; 263(5152):1453-4. PubMed ID: 8128231
[TBL] [Abstract][Full Text] [Related]
48. Thymopoiesis and T cell development in common gamma chain-deficient dogs.
Felsburg PJ; Hartnett BJ; Gouthro TA; Henthorn PS
Immunol Res; 2003; 27(2-3):235-46. PubMed ID: 12857971
[TBL] [Abstract][Full Text] [Related]
49. Screening for mutations causing X-linked severe combined immunodeficiency in the IL-2R gamma chain gene by single-strand conformation polymorphism analysis.
Clark PA; Lester T; Genet S; Jones AM; Hendriks R; Levinsky RJ; Kinnon C
Hum Genet; 1995 Oct; 96(4):427-32. PubMed ID: 7557965
[TBL] [Abstract][Full Text] [Related]
50. Two mutational hotspots in the interleukin-2 receptor gamma chain gene causing human X-linked severe combined immunodeficiency.
Pepper AE; Buckley RH; Small TN; Puck JM
Am J Hum Genet; 1995 Sep; 57(3):564-71. PubMed ID: 7668284
[TBL] [Abstract][Full Text] [Related]
51. Keratinocyte antiviral response to Poly(dA:dT) stimulation and papillomavirus infection in a canine model of X-linked severe combined immunodeficiency.
Luff JA; Yuan H; Kennedy D; Schlegel R; Felsburg P; Moore PF
PLoS One; 2014; 9(7):e102033. PubMed ID: 25025687
[TBL] [Abstract][Full Text] [Related]
52. Canine X-linked severe combined immunodeficiency. A model for investigating the requirement for the common gamma chain (gamma c) in human lymphocyte development and function.
Felsburg PJ; Somberg RL; Hartnett BJ; Henthorn PS; Carding SR
Immunol Res; 1998; 17(1-2):63-73. PubMed ID: 9479568
[TBL] [Abstract][Full Text] [Related]
53. B-cell function in canine X-linked severe combined immunodeficiency.
Hartnett BJ; Somberg RL; Krakowka S; Ochs HD; HogenEsch H; Moore PF; Weinberg KI; Felsburg PJ
Vet Immunol Immunopathol; 2000 Jun; 75(1-2):121-34. PubMed ID: 10889304
[TBL] [Abstract][Full Text] [Related]
54. Severe combined immunodeficiency, interleukin-2 (IL-2), and the IL-2 receptor: experiments of nature continue to point the way.
Voss SD; Hong R; Sondel PM
Blood; 1994 Feb; 83(3):626-35. PubMed ID: 8298124
[TBL] [Abstract][Full Text] [Related]
55. Alternative Splicing Rescues Loss of Common Gamma Chain Function and Results in IL-21R-like Deficiency.
Illig D; Navratil M; Kelečić J; Conca R; Hojsak I; Jadrešin O; Ćorić M; Vuković J; Rohlfs M; Hollizeck S; Bohne J; Klein C; Kotlarz D
J Clin Immunol; 2019 Feb; 39(2):207-215. PubMed ID: 30903457
[TBL] [Abstract][Full Text] [Related]
56. The γ
Spolski R; Gromer D; Leonard WJ
F1000Res; 2017; 6():1872. PubMed ID: 29123649
[TBL] [Abstract][Full Text] [Related]
57. Two base pair deletion in IL2 receptor γ gene in NOD/SCID mice induces a highly severe immunodeficiency.
Bak I; Kim DJ; Kim HC; Shin HJ; Yu E; Yoo KW; Yu DY
Lab Anim Res; 2020; 36():27. PubMed ID: 32817844
[TBL] [Abstract][Full Text] [Related]
58. Preclinical Development of a Lentiviral Vector for Gene Therapy of X-Linked Severe Combined Immunodeficiency.
Poletti V; Charrier S; Corre G; Gjata B; Vignaud A; Zhang F; Rothe M; Schambach A; Gaspar HB; Thrasher AJ; Mavilio F
Mol Ther Methods Clin Dev; 2018 Jun; 9():257-269. PubMed ID: 29707600
[TBL] [Abstract][Full Text] [Related]
59. Absence of γ-Chain in Keratinocytes Alters Chemokine Secretion, Resulting in Reduced Immune Cell Recruitment.
Nowak K; Linzner D; Thrasher AJ; Lambert PF; Di WL; Burns SO
J Invest Dermatol; 2017 Oct; 137(10):2120-2130. PubMed ID: 28634034
[TBL] [Abstract][Full Text] [Related]
60. Gene therapy model of X-linked severe combined immunodeficiency using a modified foamy virus vector.
Horino S; Uchiyama T; So T; Nagashima H; Sun SL; Sato M; Asao A; Haji Y; Sasahara Y; Candotti F; Tsuchiya S; Kure S; Sugamura K; Ishii N
PLoS One; 2013; 8(8):e71594. PubMed ID: 23990961
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
